2, 3-dihydroquinoline-4-ketone bioactive skeleton as well as synthesis method and application thereof
A synthetic method and technology of dihydroquinoline, applied in drug combination, non-central analgesics, antipyretics, etc., can solve the problems of long reaction time of metal catalysts, expensive chiral phosphoric acid, and poor universality of substrates , to achieve good practical significance and application value, green and efficient synthesis, and good substrate universality
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] 1. This embodiment provides a method for synthesizing a 2,3-dihydroquinolin-4-one biologically active skeleton, comprising the following steps:
[0048]Take 0.1 mmol of methyl 2-aminobenzoylacetate compound in a reaction flask, and add 1 mL of solvent, 0.15 mmol of formaldehyde compound, and catalyst in sequence. Control the reaction temperature of the system, keep stirring, trace the reaction by spotting samples on the thin-layer chromatographic plate until the reaction of the raw materials is complete. After the reaction is completed, a silica gel column is used for separation and purification, and the purified product is rotary evaporated to obtain the target product. The reaction formula is as follows:
[0049]
[0050] 2. According to the above method, set up 9 parallel test groups, using different catalysts and solvents respectively. Catalysts are acetic acid / ammonium acetate Ac(OH) / NH 4 OAc, Piperidine, Sc(OTf) 3 , copper trifluoromethanesulfonate Cu(OTf) ...
Embodiment 2
[0061] Raw materials: methyl 2-tetrahydropyrrole benzoyl acetate, benzaldehyde
[0062] Product: Formula C 21 h 21 NO 3
[0063] Molecular weight: 335.4030
[0064] Structural formula:
[0065] Yield: 79%
[0066] 1 H NMR (500MHz, CDCl 3 )δ7.69(d, J=7.9Hz, 1H), 7.38(t, J=7.7Hz, 1H), 7.09–7.02(m, 3H), 6.94(d, J=4.3Hz, 2H), 6.67( dd,J=18.1,10.7Hz,1H),6.57(d,J=8.4Hz,1H),4.17(dd,J=9.5,5.6Hz,1H),3.81(s,3H),3.48(ddd,J =17.8,15.6,8.9Hz,2H),3.32(d,J=13.7Hz,1H),2.90(d,J=13.7Hz,1H),2.20–2.12(m,1H),2.09–1.91(m, 3H). 13 C NMR (126MHz, CDCl 3 )δ190.86(s),171.96(s),148.38(s),136.30(s),135.54(s),130.71(s),129.17(s),127.47(s),126.46(s),118.29( s), 116.59(s), 112.73(s), 77.34(d, J=6.5Hz), 77.11(s), 76.86(s), 63.44(s), 61.74(s), 52.60(s), 46.83( s), 31.74(s), 26.23(s), 22.95(s).HRMS(ESI): calcd for C 21 h 21 NO 3 Na[M+Na] + :358.3922,found:358.3924.
Embodiment 3
[0068] Raw materials: methyl 2-tetrahydropyrrole benzoyl acetate, p-nitrobenzaldehyde
[0069] Product: Formula C 21 h 20 N 2 o 5
[0070] Molecular weight: 380.1372
[0071] Structural formula:
[0072] Yield: 72%
[0073] 1 H NMR (500MHz, CDCl 3 )δ7.91(d, J=8.6Hz, 1H), 7.67(d, J=7.9Hz, 1H), 7.43(t, J=7.7Hz, 1H), 7.10(d, J=8.6Hz, 1H) ,6.72(t,J=7.5Hz,1H),6.63(d,J=8.4Hz,1H),4.20(t,J=7.4Hz,1H),3.83(d,J=9.0Hz,2H),3.53 (ddd,J=17.4,11.8,7.5Hz,1H),3.43(d,J=13.5Hz,1H),2.99–2.88(m,1H),2.22(dd,J=11.5,7.6Hz,1H), 2.09–1.95(m,2H). 13 C NMR (126MHz, CDCl 3 )δ190.10(s),171.62(s),148.39(s),146.63(s),144.50(s),136.08(s),131.64(s),129.07(s),122.58(s),118.01( s), 117.10(s), 112.97(s), 77.33(s), 77.08(s), 76.83(s), 63.42(s), 61.98(s), 52.84(s), 46.88(s), 31.13( s),26.21(s),22.89(s).HRMS(ESI):calcd for C 21 h 20 N 2 o 5 Na[M+Na] + :403.3892,found:403.3896.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


